A detailed history of Gg Group Ventures, LLC transactions in Verve Therapeutics, Inc. stock. As of the latest transaction made, Gg Group Ventures, LLC holds 14,599 shares of VERV stock, worth $84,674. This represents 0.09% of its overall portfolio holdings.

Number of Shares
14,599
Holding current value
$84,674
% of portfolio
0.09%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$4.76 - $12.79 $69,491 - $186,721
14,599 New
14,599 $66.3 Million

Others Institutions Holding VERV

About Verve Therapeutics, Inc.


  • Ticker VERV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,942,300
  • Market Cap $348M
  • Description
  • Verve Therapeutics, Inc., a genetic medicines company, engages in developing gene editing medicines for patients to treat cardiovascular diseases. Its lead product candidate is VERVE-101, a single-course gene editing treatment that permanently turns off the PCSK9 gene in the liver. The company also engages in the development of ANGPTL3 program t...
More about VERV
Track This Portfolio

Track Gg Group Ventures, LLC Portfolio

Follow Gg Group Ventures, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gg Group Ventures, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gg Group Ventures, LLC with notifications on news.